May, 2011Regenerect: Recall – Undeclared Drug Ingredient
Audience: Consumer ISSUE: FDA lab analysis confirmed the presence of Sulfoaildenafil, an analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making Regenerect an unapproved drug. The product poses a…
Continue →Pfizer Reports Drug Trial Had One Death
Although four patients died in a recent clinical trial for an experimental treatment for rheumatoid arthritis, Pfizer Inc. claims that only one of those deaths was drug-related. The company added that the death rate associated with the drug, across several studies, “is within the range of rates reported for biologic therapies” for rheumatoid arthritis. The experimental drug, tofacitinib, is an oral pill that Pfizer hopes can be an alternative to injectible and infused rheumatoid-arthritis drugs. Two deaths occurred during the …
Continue →Recent Related Features
All Stories
facebook
rss
twitter